Hunan Warrant Pharmaceutical Co.,Ltd

688799

CNE100004P73

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
41.01 ^CNY	-0.70%		-4.43%	-16.20%

Apr. 19	Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 25	Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hunan Warrant Pharmaceutical Co.,Ltd(SHSE:688799) added to Shanghai Stock Exchange Composite Index

July 13, 2022 at 12:00 am EDT

Hunan Warrant Pharmaceutical Co.,Ltd Added to Shanghai Stock Exchange Composite Index

Latest news about Hunan Warrant Pharmaceutical Co.,Ltd

Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 25	CI
Warrant Pharmaceutical's Diclofenac Tablets Passes Regulatory Evaluation	Dec. 21	MT
Hunan Warrant Pharma Passes GMP Compliance Inspection	Nov. 14	MT
Warrant Pharmaceutical's Heart Disease Medication Passes Generic Drug Evaluation in China	Nov. 02	MT
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Warrant Pharmaceutical Gets Nod to Market Clopidogrel Bisulfate	23-10-23	MT
Zhuhai Qianlie Pharmaceutical Co., Ltd. announced that it expects to receive CNY 25 million in funding from Hunan Warrant Pharmaceutical Co.,Ltd	23-10-15	CI
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-27	CI
Warrant Pharma Unit Registers Arthritis Drug in South Korea	23-07-12	MT
Warrant Pharma Secures Product Registration Certificate in South Korea	23-05-22	MT
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Warrant Pharma Gets Regulatory Green Light to Issue Bonds	23-04-26	MT
Warrant Pharma Gets Registration Certificate in China for Asthma Drug	23-03-27	MT
Hunan Warrant Pharma Posts 12.2% Rise in 2022 Profit	23-02-24	MT
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-22	CI
Hunan Warrant Pharma's Drug Production Base Passes Regulator's GMP Inspection	23-02-09	MT
Hunan Warrant Pharma’s Hepatitis Drug Included in China’s Medical Insurance Catalog	23-01-19	MT
Hunan Warrant Pharma to Raise 691 Million Yuan For New Production Base	22-12-13	MT
Hunan Warrant Pharmaceutical Gets Regulatory Nod for Anemia Drug in China	22-12-06	MT
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Hunan Warrant Pharmaceutical Co.,Ltd(SHSE:688799) added to Shanghai Stock Exchange A Share Index	22-07-13	CI
Hunan Warrant Pharmaceutical Co.,Ltd(SHSE:688799) added to Shanghai Stock Exchange Composite Index	22-07-13	CI
Hunan Warrant Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-19	CI

Chart Hunan Warrant Pharmaceutical Co.,Ltd

Duration

Period

Chart Hunan Warrant Pharmaceutical Co.,Ltd

More charts

Hunan Warrant Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical raw materials, chemical pharmaceutical preparations and traditional Chinese medicine preparations. The Company's products include pharmaceutical preparations, raw materials and intermediates, plant extracts and food. Its products cover areas such as digestion, breathing, and anti-infection. The Company mainly conducts business within the domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

41.01 CNY

Average target price

59 CNY

Spread / Average Target

+43.87%

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HUNAN WARRANT PHARMACEUTICAL CO.,LTD	-16.20%	535M
ELI LILLY AND COMPANY	+38.59%	727B
JOHNSON & JOHNSON	-7.89%	354B
MERCK & CO., INC.	+15.66%	328B
ABBVIE INC.	+0.24%	277B
ASTRAZENECA PLC	+13.47%	243B
NOVARTIS AG	+7.35%	205B
ROCHE HOLDING AG	-6.42%	203B
AMGEN INC.	+4.23%	164B
PFIZER, INC.	-1.70%	164B

Other Pharmaceuticals